Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Shimizu

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 3, 2002
[Phase III study of gynecologic cancer in Japan]Yoshio Shimizu
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 28, 2002
[Recent advances in intraarterial chemotherapy in gynecologic malignancy]Yoshio Shimizu
Journal of Rural Medicine : JRM|July 10, 2025
Severe fever thrombocytopenia syndrome proceeding eastYouichi Yanagawa, Hiroki Nagasawa, Yoshio Shimizu
Medicina (Kaunas, Lithuania)|January 23, 2024
IgA Nephropathy: Beyond the Half-CenturyYoshio Shimizu, Yasuhiko Tomino, Yusuke Suzuki
International Immunopharmacology|February 19, 2008
Induction of cytolytic activity and interferon-gamma production in murine natural killer cells by polymyxins B and EMing Zhong, Yusuke Kadota, Yoshio Shimizu, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 17, 2002
Villoglandular papillary adenocarcinoma of the uterine cervix with bulky lymph node metastasesKuniko Utsugi, Yoshio Shimizu, Futoshi Akiyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 30, 2004
[Chemotherapy with combination of UFT and cisplatin against metastatic ovarian tumor originating from gastric cancer]Katsuyoshi Katase, Yoshio Shimizu, Yaeko Kobayashi, et al.
Integrative Cancer Therapies|December 8, 2016
Augmentation of Cytolytic Activity in Murine Natural Killer Cells and Inhibition of Tumor Growth by the Ethanol Fraction of Oyster ExtractKaito Sakaguchi, Ming Zhong, Saeko Kawai, et al.
Gynecologic Oncology|January 31, 2004
Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervixKuniko Utsugi, Yoshio Shimizu, Futoshi Akiyama, et al.
The Journal of Biological Chemistry|May 4, 2013
Proteasomal degradation of eukaryotic elongation factor-2 kinase (EF2K) is regulated by cAMP-PKA signaling and the SCFβTRCP ubiquitin E3 ligaseShari L Wiseman, Yoshio Shimizu, Clive Palfrey, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 3, 2002
[Phase III study of gynecologic cancer in Japan]Yoshio Shimizu
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 28, 2002
[Recent advances in intraarterial chemotherapy in gynecologic malignancy]Yoshio Shimizu
Journal of Rural Medicine : JRM|July 10, 2025
Severe fever thrombocytopenia syndrome proceeding eastYouichi Yanagawa, Hiroki Nagasawa, Yoshio Shimizu
Medicina (Kaunas, Lithuania)|January 23, 2024
IgA Nephropathy: Beyond the Half-CenturyYoshio Shimizu, Yasuhiko Tomino, Yusuke Suzuki
International Immunopharmacology|February 19, 2008
Induction of cytolytic activity and interferon-gamma production in murine natural killer cells by polymyxins B and EMing Zhong, Yusuke Kadota, Yoshio Shimizu, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 17, 2002
Villoglandular papillary adenocarcinoma of the uterine cervix with bulky lymph node metastasesKuniko Utsugi, Yoshio Shimizu, Futoshi Akiyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 30, 2004
[Chemotherapy with combination of UFT and cisplatin against metastatic ovarian tumor originating from gastric cancer]Katsuyoshi Katase, Yoshio Shimizu, Yaeko Kobayashi, et al.
Integrative Cancer Therapies|December 8, 2016
Augmentation of Cytolytic Activity in Murine Natural Killer Cells and Inhibition of Tumor Growth by the Ethanol Fraction of Oyster ExtractKaito Sakaguchi, Ming Zhong, Saeko Kawai, et al.
Gynecologic Oncology|January 31, 2004
Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervixKuniko Utsugi, Yoshio Shimizu, Futoshi Akiyama, et al.
The Journal of Biological Chemistry|May 4, 2013
Proteasomal degradation of eukaryotic elongation factor-2 kinase (EF2K) is regulated by cAMP-PKA signaling and the SCFβTRCP ubiquitin E3 ligaseShari L Wiseman, Yoshio Shimizu, Clive Palfrey, et al.
Pageof 6